bicalutamide has been researched along with Lung Diseases, Interstitial in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Li, J; Shen, P; Wu, B; Wu, F; Xu, T; Yin, X; Yu, L | 1 |
Kageyama, S; Kawauchi, A; Maeda, K; Masuda, Y; Narita, M; Osafune, T; Takeda, T | 1 |
Chertcoff, JF; Dezanzo, P; Di Tullio, F; Ernst, G; Molina Mancero, G; Picón, X; Salvado, A | 1 |
Masago, T; Motoda, K; Nemoto, R; Watanabe, T | 1 |
Sakai, N; Shioi, K; Yoshida, M | 1 |
Nakamura, M; Sakai, N; Shioi, K; Yoshida, M | 1 |
DiFabrizio, L; Macris, N; Seriff, NS; Wong, PW | 1 |
McCaffrey, JA; Scher, HI | 1 |
1 review(s) available for bicalutamide and Lung Diseases, Interstitial
Article | Year |
---|---|
Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.
Topics: Aged; Androgen Antagonists; Anilides; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Biopsy; Dyspnea; Glucocorticoids; Humans; Lung Diseases, Interstitial; Male; Methylprednisolone Hemisuccinate; Nitriles; Prostatic Neoplasms; Pulmonary Eosinophilia; Tosyl Compounds | 1998 |
7 other study(ies) available for bicalutamide and Lung Diseases, Interstitial
Article | Year |
---|---|
Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System.
Topics: Adverse Drug Reaction Reporting Systems; Androgen Antagonists; Antineoplastic Agents, Hormonal; Flutamide; Goserelin; Humans; Lung Diseases, Interstitial; Male; Prostatic Neoplasms; United States; United States Food and Drug Administration | 2023 |
[DRUG-INDUCED INTERSTITIAL LUNG DISEASE DURING COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE AND LEUPRORELIN ACETATE FOR PROSTATE CANCER].
Topics: Aged; Androgen Antagonists; Anilides; Humans; Leuprolide; Lung Diseases, Interstitial; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2019 |
[Fatal interstitial lung disease associated with maximum androgen blockade].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antinematodal Agents; Biopsy; Disease Progression; Fatal Outcome; Humans; Lung Diseases, Interstitial; Male; Nitriles; Prostatic Neoplasms; Tomography, X-Ray Computed; Tosyl Compounds | 2016 |
Interstitial pneumonitis induced by bicalutamide given for prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Bone Neoplasms; Castration; Humans; Lung Diseases, Interstitial; Male; Nitriles; Paralysis; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2011 |
Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer.
Topics: Aged; Anilides; Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Glucocorticoids; Humans; Leuprolide; Lung Diseases, Interstitial; Male; Methylprednisolone Hemisuccinate; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2003 |
Successful recovery from interstitial pneumonitis, induced by bicalutamide and leuprorelin acetate given as treatment for prostate cancer.
Topics: Adenocarcinoma; Aged; Anilides; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; Humans; Leuprolide; Lung Diseases, Interstitial; Male; Methylprednisolone Hemisuccinate; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2005 |
Interstitial pneumonitis following bicalutamide treatment for prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Humans; Lung Diseases, Interstitial; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 1998 |